Your browser doesn't support javascript.
loading
Are we prepared to deliver gene-targeted therapies for rare diseases?
Yu, Timothy W; Kingsmore, Stephen F; Green, Robert C; MacKenzie, Tippi; Wasserstein, Melissa; Caggana, Michele; Gold, Nina B; Kennedy, Annie; Kishnani, Priya S; Might, Matthew; Brooks, Phillip J; Morris, Jill A; Parisi, Melissa A; Urv, Tiina K.
Afiliação
  • Yu TW; Division of Genetics and Genomics, Harvard Medical School, Boston, Massachusetts, USA.
  • Kingsmore SF; Rady Children's Institute for Genomic Medicine, San Diego, California, USA.
  • Green RC; Department of Genetics-Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • MacKenzie T; Department of Surgery and the Center for Maternal-Fetal Precision Medicine, University of California, San Francisco, San Francisco, California, USA.
  • Wasserstein M; Division of Pediatric Genetic Medicine, Children's Hospital at Montefiore, New York, New York, USA.
  • Caggana M; Division of Genetics, New York State Department of Health, Albany, New York, USA.
  • Gold NB; Massachusetts General Hospital Department of Pediatrics, Boston, Massachusetts, USA.
  • Kennedy A; EveryLife Foundation for Rare Diseases, Washington, District of Columbia, USA.
  • Kishnani PS; Department of Pediatrics, Duke University, Durham, North Carolina, USA.
  • Might M; Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Brooks PJ; Office of Rare Disease Research, National Center for Advancing Translational Science, National Institutes of Health, Bethesda, Maryland, USA.
  • Morris JA; Division of Neuroscience, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • Parisi MA; Intellectual and Developmental Disabilities Branch, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
  • Urv TK; Office of Rare Disease Research, National Center for Advancing Translational Science, National Institutes of Health, Bethesda, Maryland, USA.
Am J Med Genet C Semin Med Genet ; 193(1): 7-12, 2023 03.
Article em En | MEDLINE | ID: mdl-36691939

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Doenças Raras Limite: Humans Idioma: En Revista: Am J Med Genet C Semin Med Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Doenças Raras Limite: Humans Idioma: En Revista: Am J Med Genet C Semin Med Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos